| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
Institut für Pharmakologie (A.S., K.S., G.S., T.S.), Freie Universität Berlin, Universitätsklinikum Benjamin Franklin, 14195 Berlin, Germany; Kinderklinik und Poliklinik (T.L.), Universitätsklinikum Benjamin Franklin, 12200 Berlin, Germany; Kinder- und Jugendklinik (M.W.), Medizinische Fakultät Universität Rostock, 18055 Rostock, Germany; Royal Manchester Childrens Hospital (D.A.P.), Pendlebury, Manchester M27 4HA, United Kingdom; Department of Paediatrics (A.N.), Central Hospital of Central Finland, 40620 Jyväskylä, Finland; and Klinik und Poliklinik für Kinderheilkunde (A.G.), Virchow-Klinikum, Medizinische Fakultät der Humboldt Universität zu Berlin, 13353 Berlin, Germany
Address all correspondence and requests for reprints to: Torsten Schöneberg, Institut für Pharmakologie, Freie Universität Berlin, Thielallee 69-73, 14195 Berlin, Germany. E-mail: schoberg{at}zedat.fu-berlin.de.
Abstract
By screening patients with X-linked nephrogenic diabetes insipidus (NDI) for mutations within the V2 vasopressin receptor (AVPR2) gene, we have identified six novel and two recurrent mutations. Additionally, one patient revealed a genomic deletion of 3.2 kb encompassing most of the AVPR2 gene and the last exon/3'-region of C1 gene, which is in close proximity to the AVPR2 locus. In-depth characterization of the mutant AVPR2s by a combination of functional and immunological techniques allowed to gain further insight into molecular mechanisms leading to the receptor dysfunction. Aiming at the functional reconstitution of mutant G protein-coupled receptors, several strategies of potential therapeutic usefulness have been tested. Because the functional rescue of truncated receptors is most challenging, we addressed this issue by applying an aminoglycoside approach. Here, we demonstrate that the misreading capacity of the aminoglycoside antibiotic geneticin was sufficient to restore function of mutant AVPR2s harboring premature stop codons in an in vitro expression system.
This article has been cited by other articles:
![]() |
C. Yang, J. Feng, W. Song, J. Wang, B. Tsai, Y. Zhang, W. A. Scaringe, K. A. Hill, P. Margaritis, K. A. High, et al. A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin PNAS, September 25, 2007; 104(39): 15394 - 15399. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Robben, N. V. A. M. Knoers, and P. M. T. Deen Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol, August 1, 2006; 291(2): F257 - F270. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zaki, T. Schoneberg, T. Al Ajrawi, A. N. Al Said, K. Sangkuhl, and H. Rompler Nephrogenic diabetes insipidus, thiazide treatment and renal cell carcinoma Nephrol. Dial. Transplant., April 1, 2006; 21(4): 1082 - 1086. [Full Text] [PDF] |
||||
![]() |
D. E. Handy, G. Hang, J. Scolaro, N. Metes, N. Razaq, Y. Yang, and J. Loscalzo Aminoglycosides Decrease Glutathione Peroxidase-1 Activity by Interfering with Selenocysteine Incorporation J. Biol. Chem., February 10, 2006; 281(6): 3382 - 3388. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Lai, H. H. Chun, S. A. Nahas, M. Mitui, K. M. Gamo, L. Du, and R. A. Gatti Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons PNAS, November 2, 2004; 101(44): 15676 - 15681. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sangkuhl, A. Schulz, H. Rompler, J. Yun, J. Wess, and T. Schoneberg Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo Hum. Mol. Genet., May 1, 2004; 13(9): 893 - 903. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |